VEGFA and neoplasm: In this study, we further found that treatment with andrographolide in lung tumor animal model effectively reduced the expression of VEGF in tumor tissue; this activity demonstrates that andrographolide may prove a potent antiangiogenic agent for the treatment of pulmonary cancer.